Harvard Study: Half of Adult Americans Eligible for Ozempic-Like Drugs
Obesity, Diabetes, and Fat-Related Comorbidities Could Call for Once Weekly Injections
By Peter A. McCullough, MD, MPH
Glucagon-like peptide receptor agonists (GLP-1 RA) are the current financial rainmakers for BIG PHARMA.
Shi et al from Harvard reported recently in JAMA Cardiology.
Rapidly increasing uptake of semaglutide made it the top-selling drug in the US in 2023, with net sales of $13.8 billion. Quantifying the number of US adults eligible for semaglutide may guide future policies for this high-cost therapy and clarify potential implications for pharmaceutical spending.
The authors conclude that approximately 137 million adults or half the of the US population could have a clinical indication for once weekly GLP-1 RA drugs. This budget breaking conclusion no doubt will have to be addressed by the incoming HHS administration led by Robert F. Kennedy, Jr.
GLP-1 RAs mimic the actions of the GLP-1 hormone, which is released in the gut after eating. This stimulates the release of insulin and reduces blood sugar levels.
Benefits
GLP-1 RAs can help with:
Blood sugar: GLP-1 RAs are effective at lowering blood sugar levels after meals and during fasting. They are also unlikely to cause hypoglycemia (low blood sugar).
Weight: GLP-1 RAs can help with weight reduction.
Heart health: GLP-1 RAs may have benefits for heart health, including reducing the risk of heart attacks.
Kidney function: GLP-1 RAs may have benefits for kidney function.
Thus there are significant benefits, however the effect on weight reduction is transient and about two thirds regain the weight that is lost after stopping the shots.
Please subscribe to Courageous Discourse as a paying ($5 monthly) or founder member so we can continue to bring you the truth.
Peter A. McCullough, MD, MPH
President, McCullough Foundation
www.mcculloughfnd.org
This is the second time this week that the Good Doctor has written an article promoting the good results from GLP-1 drugs with nary a mention of the ill side effects that many suffer. Unfortunately this seems to be the conventional wisdom among doctors who are writing prescriptions for these drugs seemingly unaware that there can be a downside. Kind of reminds me of the mRNA vaccines that the doctor has done so much to fight.
As I mentioned in a comment on the previous article, my experience with these drugs was very harmful. If you haven't seen it already, here is my Substack about, "My year of living painfully!"
https://corrin.substack.com/p/my-year-of-living-painfully
Constant media exposure to “before-and-after” transformations fuels the desire for people to achieve rapid results. Constant media exposure to smoking made harmful products look alluring back in the day also. Like the end of smoking commercials, the new administration will put an end to pharmaceutical advertising, replacing it with attractive healthy lifestyles, and slowly but surely Americans will become healthy again.